Painreform Valuation
| PRFX Stock | USD 0.76 0.02 2.56% |
Painreform is overvalued. Painreform holds a recent Real Value of $0.73 per share. The prevailing price of the company is $0.76. Our model determines the value of Painreform from analyzing the company fundamentals such as Shares Outstanding of 2.01 M, return on equity of -1.28, and Shares Owned By Institutions of 2.45 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Painreform's price fluctuation is out of control at this time. Calculation of the real value of Painreform is based on 3 months time horizon. Increasing Painreform's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Painreform is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Painreform Stock. However, Painreform's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.76 | Real 0.73 | Hype 0.76 | Naive 0.92 |
The intrinsic value of Painreform's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Painreform's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Painreform helps investors to forecast how Painreform stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Painreform more accurately as focusing exclusively on Painreform's fundamentals will not take into account other important factors: About Painreform Valuation
Our relative valuation model uses a comparative analysis of Painreform. We calculate exposure to Painreform's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Painreform's related companies.PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. Painreform is traded on NASDAQ Exchange in the United States.
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.